Return to Statistics Toolbox

Correlation analysis for Study ST003484

Nodes mapped to chemical classification via RefMet
Select one or more experimental factors.
SelectExperimental factors
Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells (3)
Analysis:  Combine data for all analyses?:

  logo